Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking strategy to diabetes management. These innovative therapies operate by mimicking the natural actions of GLP-1, a hormone released by the https://hotbookmarkings.com/story20794103/reta-glucagon-like-peptide-1-receptor-agonists